StonvexLoading…
StonvexStonvexStonvexCore line items from KBH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $6.24B | $6.93B | $6.41B | $6.90B |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $428.79M | $655.02M | $590.18M | $816.67M |
EPS (Diluted) | $6.15 | $8.45 | $7.03 | $9.09 |
Total Assets | $6.68B | $6.94B | $6.65B | $6.65B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $230.44M | $599.19M | $727.34M | $330.20M |
Free Cash Flow OCF − CapEx | $287.28M | $323.41M | $1.05B | $138.18M |
Shares Outstanding | 69.25M | 76.95M | 83.38M | 89.35M |